{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:53:01Z","timestamp":1791201181393,"version":"4.2.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Danish Medical Council","award":["09-066348\/FSS"],"award-info":[{"award-number":["09-066348\/FSS"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbi.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T13:16:34Z","timestamp":1426079794000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset"],"prefix":"10.1016","volume":"49","author":[{"given":"Birgitte Rahbek","family":"Kornum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Jennum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2015.03.004_b0005","doi-asserted-by":"crossref","first-page":"1247-55F","DOI":"10.5665\/sleep.2080","article-title":"Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy","volume":"35","author":"Andlauer","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2015.03.004_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(08)70140-6","article-title":"CSF hypocretin-1 assessment in sleep and neurological disorders","volume":"7","author":"Bourgin","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2015.03.004_b0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbi.2015.03.004_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","article-title":"Validation and comparison of two multiplex technologies, luminex and mesoscale discovery, for human cytokine profiling","volume":"340","author":"Chowdhury","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbi.2015.03.004_b0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2015.03.004_b0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/sleep\/33.11.1428","article-title":"Post-H1N1 narcolepsy\u2013cataplexy","volume":"33","author":"Dauvilliers","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2015.03.004_b0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2013.12.019","article-title":"Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case\u2013control study","volume":"37","author":"Dauvilliers","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.03.004_b0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(81)91389-1","article-title":"HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines","volume":"2","author":"Ennis","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2015.03.004_b0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variables in patients with narcolepsy","volume":"81","author":"Fredrikson","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbi.2015.03.004_b0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2015.03.004_b0055","series-title":"International classification of sleep disorders","author":"ISCD-3","year":"2014"},{"key":"10.1016\/j.bbi.2015.03.004_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/sleep\/33.2.169","article-title":"Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population","volume":"33","author":"Knudsen","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2015.03.004_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","article-title":"Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency","volume":"79","author":"Knudsen","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2015.03.004_b0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng.734","article-title":"Common variants in are associated with narcolepsy","volume":"43","author":"Kornum","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbi.2015.03.004_b0075","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2015.03.004_b0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1440-1711.2005.01365.x","article-title":"Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation","volume":"83","author":"Lebre","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbi.2015.03.004_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-5728(91)90073-G","article-title":"Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis","volume":"32","author":"Maimone","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.03.004_b0090","doi-asserted-by":"crossref","first-page":"e61835","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.03.004_b0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1352458509355068","article-title":"Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid","volume":"16","author":"Mellerg\u00e5rd","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2015.03.004_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2015.03.004_b0105","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.03.004_b0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: the role of H1N1 vaccination and natural infection","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.bbi.2015.03.004_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1439-054X.2004.00023.x","article-title":"Oligoclonal bands and specific antibody indices in human narcolepsy","volume":"8","author":"Schuld","year":"2004","journal-title":"Somnologie"},{"key":"10.1016\/j.bbi.2015.03.004_b0115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.sleep.2014.01.015","article-title":"Delayed diagnosis of narcolepsy: characterization and impact","volume":"15","author":"Thorpy","year":"2014","journal-title":"Sleep Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:41:29Z","timestamp":1760168489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159115000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":24,"alternative-id":["S0889159115000756"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2015.03.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}